(Q33279090)

25 July 2017

title

Combined flow cytometry and confocal laser scanning microscopy for evaluation of BR96 antibody cancer cell targeting and internalization (English)

1 reference

25 July 2017

1 reference

1 reference

Amir H Iranpour Feridani

1

1 reference

25 July 2017

Bo Holmqvist

2

1 reference

25 July 2017

Hans-Olov Sjögren

3

1 reference

25 July 2017

Sven-Erik Strand

4

1 reference

25 July 2017

Jan Tennvall

5

1 reference

25 July 2017

Bo Baldetorp

6

1 reference

25 July 2017

publication date

1 June 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

71

1 reference

25 July 2017

issue

6

1 reference

25 July 2017

page(s)

361-370

1 reference

Treatment of acute leukaemias with monoclonal antibodies: current status and future prospects.

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

Targeted therapy of cancer: new prospects for antibodies and immunoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Monoclonal antibody mediated intracellular targeting of tallysomycin S(10b)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Drug-conjugated monoclonal antibodies for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Monoclonal antibodies for the treatment of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Clinical applications of newer radionuclide therapies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Intracellular delivery of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with lewis Y-expressing epithelial tumors

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Analysis of the expression of H, Lewis, X, Y and precursor blood group determinants in saliva and red cells using a panel of mouse monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Structural convergence of antibody binding of carbohydrate determinants in Lewis Y tumor antigens

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Novel flow cytometric analysis of the progress and route of internalization of a monoclonal anti-carcinoembryonic antigen (CEA) antibody

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Quality assessment of confocal microscopy slide based systems: performance

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

7-Amino-actinomycin D as a specific fluorophore for DNA content analysis by laser flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Determining maximal tolerable dose of the monoclonal antibody BR96 labeled with 90Y or 177Lu in rats: establishment of a syngeneic tumor model to evaluate means to improve radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Blood pharmacokinetics of various monoclonal antibodies labeled with a new trifunctional chelating reagent for simultaneous conjugation with 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid and biotin before radiolabeling.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20388

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.20388

1 reference

release_63infa56tzerjioejicykcshfa

25 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/63infa56tzerjioejicykcshfa

24 November 2022

mapped directly with Wikidata item

1 reference